Volume 36, Issue 4 (12-2025)
Studies in Medical Sciences 2025, 36(4): 43-49 |
Back to browse issues page
Ethics code: IR.IAU.SARI.REC.1404.155
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Askari B, Falahati Shahabodini M, Farajtabar Behrestaq S, Taghipoor A. The Effect of Eight Weeks of Aerobic Training and Resveratrol Consumption on the Expression of p21 and p16 in the Liver Tissue of Rats with NAFLD. Studies in Medical Sciences 2025; 36 (4) :43-49
URL: http://umj.umsu.ac.ir/article-1-6466-en.html
URL: http://umj.umsu.ac.ir/article-1-6466-en.html
Qaemshahr Branch, Islamic Azad University , b.askari.1359@iau.ac.ir
Abstract: (230 Views)
Background: Exercise training, resveratrol supplementation, and cellular aging are important issues in nonalcoholic fatty liver disease. The present study aimed to investigate the effect of 8 weeks of aerobic training and resveratrol consumption on the expression of some indicators of cellular aging in the liver tissue of a nonalcoholic fatty liver disease rat model.
Methods: In the present experimental study, 35 eight-week-old male Wistar rats were randomly divided into two groups: patients with nonalcoholic fatty liver disease and a control group. Then, the rats in the control group were placed on a standard diet for 6 weeks, while to induce nonalcoholic fatty liver disease in the rats, the animals were placed on a high-fat diet for 6 weeks. The rats in the patient group were further divided into four experimental subgroups: non-alcoholic fatty liver, non-alcoholic fatty liver-exercise, non-alcoholic fatty liver-resveratrol, and non-alcoholic fatty liver-exercise-resveratrol. The rats in the exercise group underwent an eight-week (5 days/week) aerobic interval-training program. Rats in the supplement group were injected intraperitoneally with 20 mg/kg of resveratrol per day for 8 weeks.
Results: The results showed a significant increase in the rate of changes in p21 expression in the non-alcoholic fatty liver (p = 0.0001), non-alcoholic fatty liver-exercise (p = 0.002), and non-alcoholic fatty liver-resveratrol (p = 0.002) groups compared to healthy controls, and also a significant increase in the rate of changes in p16 expression in the non-alcoholic fatty liver (p = 0.0001), non-alcoholic fatty liver-exercise (p = 0.006), and non-alcoholic fatty liver-resveratrol (p = 0.003) groups compared to healthy controls.
Conclusion: Treating nonalcoholic fatty liver disease with exercise and resveratrol improves markers of liver aging in rats. Eliminating or reducing cellular markers using exercise and resveratrol may be an effective strategy for improving liver damage associated with nonalcoholic fatty liver disease.
Methods: In the present experimental study, 35 eight-week-old male Wistar rats were randomly divided into two groups: patients with nonalcoholic fatty liver disease and a control group. Then, the rats in the control group were placed on a standard diet for 6 weeks, while to induce nonalcoholic fatty liver disease in the rats, the animals were placed on a high-fat diet for 6 weeks. The rats in the patient group were further divided into four experimental subgroups: non-alcoholic fatty liver, non-alcoholic fatty liver-exercise, non-alcoholic fatty liver-resveratrol, and non-alcoholic fatty liver-exercise-resveratrol. The rats in the exercise group underwent an eight-week (5 days/week) aerobic interval-training program. Rats in the supplement group were injected intraperitoneally with 20 mg/kg of resveratrol per day for 8 weeks.
Results: The results showed a significant increase in the rate of changes in p21 expression in the non-alcoholic fatty liver (p = 0.0001), non-alcoholic fatty liver-exercise (p = 0.002), and non-alcoholic fatty liver-resveratrol (p = 0.002) groups compared to healthy controls, and also a significant increase in the rate of changes in p16 expression in the non-alcoholic fatty liver (p = 0.0001), non-alcoholic fatty liver-exercise (p = 0.006), and non-alcoholic fatty liver-resveratrol (p = 0.003) groups compared to healthy controls.
Conclusion: Treating nonalcoholic fatty liver disease with exercise and resveratrol improves markers of liver aging in rats. Eliminating or reducing cellular markers using exercise and resveratrol may be an effective strategy for improving liver damage associated with nonalcoholic fatty liver disease.
Keywords: Aerobic Training, Cyclin-dependent kinase inhibitor p16, Cyclin-dependent kinase inhibitor p21, Non-alcoholic Fatty Liver Disease, Resveratrol
Type of Study: Research |
Subject:
Exercise physiology
References
1. Takahashi H, Kotani K, Tanaka K, Eguchi Y, Anzai KJFie. Therapeutic approaches to nonalcoholic fatty liver disease: exercise intervention and related mechanisms. Frontiers in Endocrinology. 2018;9:588. [DOI:10.3389/fendo.2018.00588] [PMID] [PMCID]
2. Dongiovanni P, Valenti LJM. Genetics of nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1026-37. [DOI:10.1016/j.metabol.2015.08.018] [PMID]
3. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RAJS. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science . 2000;287(5456):1253-8. [DOI:10.1126/science.287.5456.1253] [PMID]
4. Aravinthan A, Scarpini C, Tachtatzis P, Verma S, Penrhyn-Lowe S, Harvey R, et al. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. Journal of hepatology. 2013;58(3):549-56. [DOI:10.1016/j.jhep.2012.10.031] [PMID]
5. 5 .Ludlow AT, Witkowski S, Marshall MR, Wang J, Lima LC, Guth LM, et al. Chronic exercise modifies age-related telomere dynamics in a tissue-specific fashion. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2012;67(9):911-26. [DOI:10.1093/gerona/gls002] [PMID] [PMCID]
6. Ge HU, Fei QI, Jianmin CA, Zhe JI, Qiyun ZH, Haitao ZH. Curcumin Combined with Aerobic Exercise Improved Liver Function in Rats with Non-alcoholic Fatty Liver Disease. Food Science. 2025 May 25;46(10):178-87. [GOOGLE SCHOLAR]
7. Payekari S, Rahimi A, Aghaei F, Feizollahi F. Simultaneous effect of mealworm supplement with aerobic exercise on mitochondrial genes expression in the soleus muscle of rats with non-alcoholic fatty liver. Journal of Practical Studies of Biosciences in Sport. 2025 Apr 8. [GOOGLE SCHOLAR]
8. Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, Pöss J, et al. Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. Journal of the American College of Cardiology. 2008;52(6):470-82. [DOI:10.1016/j.jacc.2008.04.034] [PMID]
9. Chau MN, El Touny LH, Jagadeesh S, Banerjee PPJC. Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. Carcinogenesis. 2007;28(11):2282-90. [DOI:10.1093/carcin/bgm148] [PMID]
10. Mahmoud AM, Yang W, Bosland MCJTJosb, biology m. Soy isoflavones and prostate cancer: a review of molecular mechanisms. The Journal of steroid biochemistry and molecular biology. 2014;140:116-32. [DOI:10.1016/j.jsbmb.2013.12.010] [PMID] [PMCID]
11. Chaplin A, Carpéné C, Mercader J. Resveratrol, metabolic syndrome, and gut microbiota. Nutrients. 2018;10(11):1651. [DOI:10.3390/nu10111651] [PMID] [PMCID]
12. Soltani S, Sharifi-Zahabi E, Sangsefidi ZS, Ahmadi Vasmehjani A, Meshkini F, Clayton ZS, Abdollahi S. The effect of resveratrol supplementation on biomarkers of liver health: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2023 Mar;37(3):1153-1166. [DOI:10.1002/ptr.7719] [PMID]
13. Ranneh Y, Bedir AS, Abu-Elsaoud AM, Al Raish S. Polyphenol Intervention Ameliorates Non-Alcoholic Fatty Liver Disease: An Updated Comprehensive Systematic Review. Nutrients. 2024 Nov 29;16(23):4150. [DOI:10.3390/nu16234150] [PMID] [PMCID]
14. Mohammadhasani K, Vahedi Fard M, Mottaghi Moghaddam Shahri A, Khorasanchi Z. Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review. Food science & nutrition. 2024 Aug;12(8):5341-56. [DOI:10.1002/fsn3.4178] [PMID] [PMCID]
15. Efati M, Khorrami M, Zarei MA, SARSHOORI R. Induction of an animal model of non-alcoholic fatty liver disease using a formulated high-fat diet. Journal of Babol University of Medical Sciences. 2016;18(11):57-62. [GOOGLE SCHOLAR]
16. Linden MA, Fletcher JA, Morris EM, Meers GM, Laughlin MH, Booth FW, et al. Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training. Medicine and science in sports and exercise. 2015;47(3):556. [DOI:10.1249/MSS.0000000000000430] [PMID] [PMCID]
17. Hajighasem A, Farzanegi P, Mazaheri ZJAop, biochemistry. Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease. Archives of physiology and biochemistry. 2019;125(2):142-9. [DOI:10.1080/13813455.2018.1441872] [PMID]
18. Kim SR, Jiang K, Ogrodnik M, Chen X, Zhu X-Y, Lohmeier H, et al. Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin. Translational Research. 2019; 213:112-23. [DOI:10.1016/j.trsl.2019.07.005] [PMID] [PMCID]
19. Zhang X, Zhou D, Strakovsky R, Zhang Y, Pan Y-XJAJoP-G, Physiology L. Hepatic cellular senescence pathway genes are induced through histone modifications in a diet-induced obese rat model. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2012;302(5): G558-G64. [DOI:10.1152/ajpgi.00032.2011] [PMID] [PMCID]
20. Liao P, Yang D, Liu D, Zheng YJCP, Biochemistry. GLP-1 and ghrelin attenuate high glucose/high lipid-induced apoptosis and senescence of human microvascular endothelial cells. Cellular Physiology and Biochemistry. 2018 Jan 30;44(5):1842-55. [DOI:10.1159/000485820] [PMID]
21. Freund A, Patil CK, Campisi JJTEj. p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotype. The EMBO journal. 2011;30(8):1536-48. [DOI:10.1038/emboj.2011.69] [PMID] [PMCID]
22. Zhao X, Dong Y, Zhang J, Li D, Hu G, Yao J, et al. Leptin changes differentiation fate and induces senescence in chondrogenic progenitor cells. Cell death & disease. 2016;7(4): e2188-e. [DOI:10.1038/cddis.2016.68] [PMID] [PMCID]
23. Yu S, Kim SR, Jiang K, Ogrodnik M, Zhu XY, Ferguson CM, et al. Quercetin reverses cardiac systolic dysfunction in mice fed with a high‐fat diet: role of angiogenesis. Oxidative medicine and cellular longevity. 2021;2021(1):8875729. [DOI:10.1155/2021/8875729] [PMID] [PMCID]
24. Schafer MJ, White TA, Evans G, Tonne JM, Verzosa GC, Stout MB, et al. Exercise prevents diet-induced cellular senescence in adipose tissue. Diabetes. 2016 Jun 1;65(6):1606-15. [DOI:10.2337/db15-0291] [PMID] [PMCID]
25. Rossman MJ, Kaplon RE, Hill SD, McNamara MN, Santos-Parker JR, Pierce GL, et al. Endothelial cell senescence with aging in healthy humans: prevention by habitual exercise and relation to vascular endothelial function. American journal of physiology-Heart and circulatory physiology. 2017;313(5):H890-H5. [DOI:10.1152/ajpheart.00416.2017] [PMID] [PMCID]
26. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, Van Der Horst CM, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005 Aug 4;436(7051):720-4. [DOI:10.1038/nature03890] [PMID]
27. Safdar A, Bourgeois JM, Ogborn DI, Little JP, Hettinga BP, Akhtar M, et al. Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proceedings of the National Academy of Sciences. 2011;108(10):4135-40. [DOI:10.1073/pnas.1019581108] [PMID] [PMCID]
28. de Medina PJMH. Deciphering the metabolic secret of longevity through the analysis of metabolic response to stress on long-lived species. Medical hypotheses. 2019; 122:62-7. [DOI:10.1016/j.mehy.2018.10.019] [PMID]
29. Kunugi H, Mohammed Ali AJIjoms. Royal jelly and its components promote healthy aging and longevity: from animal models to humans. International journal of molecular sciences. 2019;20(19):4662. [DOI:10.3390/ijms20194662] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
